Accessible MRPS Spectradyne offers a rapid, cartridge-based microfluidic resistive pulse sensing solution that analyzes particles from 50 nm to 10 µm with very small sample requirements, presenting a compelling value proposition for customers needing precise particle counting and sizing in life science and materials applications.

Target Markets Primary opportunities exist in extracellular vesicle research, gene therapy, nanomedicine, vaccine development, lipid nanoparticles, and industrial nanoparticle grading, where MRPS can outperform optical methods and enable direct analysis of complex samples.

Low Footprint With a small team and early-stage revenue, Spectradyne can accelerate sales through strategic partnerships, early adopter programs, and support bundles that showcase quick ROI for labs upgrading from traditional light-scattering methods.

Freemium Demonstration The company already emphasizes free sample measurements to demonstrate value; expanding this with targeted case studies and pilot programs could convert researchers into paying customers seeking repeat measurements and broader adoption.

Growth Partnerships There is potential to align with contract research organizations, academic consortia, and instrument distributors in life sciences and materials testing to widen reach, share cost of adoption, and integrate MRPS into existing workflows.